Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

cbdMD (YCBD) Return on Equity (2017 - 2025)

cbdMD's Return on Equity history spans 9 years, with the latest figure at 0.29% for Q4 2025.

  • For Q4 2025, Return on Equity rose 160.0% year-over-year to 0.29%; the TTM value through Dec 2025 reached 0.29%, up 160.0%, while the annual FY2025 figure was 0.44%, 23.0% up from the prior year.
  • Return on Equity for Q4 2025 was 0.29% at cbdMD, up from 0.31% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.02% in Q2 2021 and bottomed at 6.65% in Q2 2024.
  • The 5-year median for Return on Equity is 0.88% (2022), against an average of 1.42%.
  • The largest annual shift saw Return on Equity crashed -581bps in 2024 before it skyrocketed 620bps in 2025.
  • A 5-year view of Return on Equity shows it stood at 0.22% in 2021, then crashed by -744bps to 1.89% in 2022, then tumbled by -32bps to 2.5% in 2023, then grew by 24bps to 1.89% in 2024, then surged by 85bps to 0.29% in 2025.
  • Per Business Quant, the three most recent readings for YCBD's Return on Equity are 0.29% (Q4 2025), 0.31% (Q3 2025), and 0.45% (Q2 2025).